# Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2

> **NCT04858854** · NA · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 100 (actual)

## Conditions studied

- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease stage4
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** Sulforaphane, administered as Broccoli sprout extract

## Key facts

- **NCT ID:** NCT04858854
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-10
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-05-18
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858854, "Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04858854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
